Dacarbazine as a minor groove binder of DNA: Spectroscopic, biophysical and molecular docking studies

被引:36
作者
Ahmad, Irshad [1 ]
Ahmad, Masood [1 ]
机构
[1] Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh 202002, Uttar Pradesh, India
关键词
Dacarbazine; Calf thymus DNA; Molecular docking; CALF THYMUS DNA; FLUORESCENCE-SPECTRA; BINDING INTERACTION; ANTITUMOR AGENT; NUCLEIC-ACID; DRUG; MODE; THERMODYNAMICS; NSC-45388; BEHAVIOR;
D O I
10.1016/j.ijbiomac.2015.04.055
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A detailed investigation on the mode of action and binding mechanism of a potent anticancer drug, 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DCR) with calf thymus DNA (ctDNA) was carried out. UV-vis and fluorescence spectrophotometry suggested the formation of complex between DCR and ctDNA. The binding constant (K-b) determined by ITC was 7.89 x 10(4) M-1. Thermodynamic parameters obtained by isothermal calorimetry suggested the spontaneous free energy (Delta G< 0) and large favorable enthalpy driven (Delta H< 0) reaction, indicating the key role of hydrogen bonding and van der Waals forces in groove binding process. Moreover, DNA-melting and circular dichroism as well as competitive displacement studies with ethidium bromide, Hoechst 33258 and potassium iodide, clearly established the formation of a groove binding system between the DCR and ctDNA. Molecular docking analysis further confirmed DCR to be a minor groove binder involving hydrogen bonding mediated 'A-T'-rich region of 'B-DNA'. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:193 / 200
页数:8
相关论文
共 61 条
[1]   Rationalising sequence selection by ligand assemblies in the DNA minor groove: the case for thiazotropsin A [J].
Alniss, Hasan Y. ;
Anthony, Nahoum G. ;
Khalaf, Abedawn I. ;
Mackay, Simon P. ;
Suckling, Colin J. ;
Waigh, Roger D. ;
Wheate, Nial J. ;
Parkinson, John A. .
CHEMICAL SCIENCE, 2012, 3 (03) :711-722
[2]   Studies on the interaction of isoxazolcurcumin with calf thymus DNA [J].
Bera, Rabindranath ;
Sahoo, Bijaya K. ;
Ghosh, Kalyan S. ;
Dasgupta, Swagata .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2008, 42 (01) :14-21
[3]   CHEMOTHERAPY OF SOFT-TISSUE SARCOMAS [J].
BERETTA, G ;
FRASCHINI, P ;
TEDESCHI, L .
ONCOLOGY, 1980, 37 :92-96
[4]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[5]   EVOLUTION IN THE TREATMENT STRATEGY OF HODGKINS-DISEASE [J].
BONADONNA, G ;
SANTORO, A .
ADVANCES IN CANCER RESEARCH, 1982, 36 :257-293
[6]   5-(3,3-DIMETHYL-1-TRIAZENO)-IMIDAZOLE-4-CARBOXAMIDE (DTIC, DIC, NSC-45388) - NEW ANTITUMOR AGENT WITH ACTIVITY AGAINST MALIGNANT-MELANOMA [J].
CARTER, SK ;
FRIEDMAN, MA .
EUROPEAN JOURNAL OF CANCER, 1972, 8 (01) :85-&
[7]  
Colvin M., 1990, ALKYLATING AGENTS CA
[8]  
Delano W.L., 2002, PYMOL MOL GRAPHICS S, V30, P442
[9]   Re-evaluating the role of dacarbazine in metastatic melanoma: what have we learned in 30 years? [J].
Eggermont, AMM ;
Kirkwood, JM .
EUROPEAN JOURNAL OF CANCER, 2004, 40 (12) :1825-1836
[10]  
Frisch M. J., 2004, GAUSSIAN 03 REVISION